Surmodics

What Surmodics does

Surmodics IVD, Inc., a division of publicly traded Surmodics, Inc. (NASDAQ: SRDX), manufactures and supplies critical components used by in vitro diagnostic (IVD) companies to develop sensitive, reproducible immunoassays. Headquartered in Eden Prairie, Minnesota since 1979, the company sells protein stabilizers (StabilCoat, StabilGuard, StabilMax, StabilZyme), blocking buffers and diluents (StabilBlot, MatrixGuard, BioFX PBSC/TBSC), ELISA substrates across colorimetric and chemiluminescent chemistries (BioFX TMB variants, ABTS, pNPP/PNPS, BCIP/NBT, DAB), proprietary TMB stop solutions (Nova-Stop, 450/650 nm reagents), microarray slides/surfaces, and — through partner DIARECT in Germany — antigens and antibodies. Technical differentiators include sub-5% lot-to-lot variation, 3–5 year shelf life, and formulations addressing heterophilic antibody interference (HAMA, rheumatoid factor).

The business operates a hybrid go-to-market combining direct e-commerce sales through shop.surmodics.com with a global distributor network covering Africa, Asia Pacific/Middle East, Canada, Central South America, Europe, and the United States. Revenue is generated primarily through unit-priced one-time sales of reagents and components to IVD assay developers, with disclosed SKU pricing ranging from approximately $20 to $355 per bottle. Manufacturing is conducted under ISO 13485:2016 and ISO 9001:2015 certifications (valid through 2026), and the company positions its in-house scientific team (chemistry, biochemistry, molecular biology, cell biology) as an extension of customer R&D functions for assay troubleshooting. End markets include ELISA/EIA, immunoblot/Western blot, line assay, microarray, lateral flow, and point-of-care diagnostic developers.

Name

Surmodics

Legal name

Surmodics IVD, Inc.

Website

https://shop.surmodics.com

Company type

Public

Founded year

1979

Operating status

Operating

Headcount range

251–500 employees

Short description

Surmodics IVD manufactures critical immunoassay components — protein stabilizers, blocking buffers, TMB substrates, stop solutions, diluents, and microarray surfaces — for in vitro diagnostic companies developing ELISA, Western blot, microarray, and lateral flow assays, distributed globally via e-commerce and a six-region distributor network.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Functional Service Providers (FSP) & Resourcing CROs (HLAGAAAM)

akta.pro secondary industries

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM), Clinical Chemistry & Immunoassay Systems (HLAHAAAA)

Keywords

• In vitro diagnostics
• Immunoassay reagents
• ELISA substrates
• Protein stabilizers
• Diagnostic components

Headquarters

HQ city

Eden Prairie

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. IVD Component Reagents: Surmodics generates revenue through the sale of in vitro diagnostic reagents and components to IVD assay developers and manufacturers. Their product portfolio includes protein stabilizers, blocking buffers, detection substrates, stop solutions, diluents, microarray slides, and biological components (antigens & antibodies).

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

Surmodics IVD manufactures and supplies critical components for developing sensitive, reproducible immunoassays, including protein stabilizers, blocking buffers, detection substrates (TMB, ABTS, pNPP, BCIP/NBT), stop solutions, diluents, microarray slides/surfaces, and antigens & antibodies. These products are used by in vitro diagnostic companies developing ELISA/EIA, immunoblot/western blot, line assay, and microarray applications, manufactured under ISO 13485:2016 and ISO 9001:2015 certifications.

Product overview

Surmodics IVD is a provider of in vitro diagnostic components for immunoassay development, offering a comprehensive portfolio of reagents for ELISA, lateral flow, Western blot, and microarray applications. The product portfolio centers on three main categories: (1) ELISA Protein Stabilizers, Diluents & Blockers including MatrixGuard Diluent, Assay Diluent (Protein-Free), and StabilBlot and BioFX blocking buffers for various immunoassay formats; (2) ELISA Substrates featuring the BioFX TMB substrate family with multiple kinetic variants (TMBW, TMBHD, TMBS, TMBX, TMDS, TMSK, TTMB, TMBC) plus ABTS, pNPP, BCIP/NBT, and DAB substrates; and (3) TMB Stop Solutions including the BioFX Nova-Stop and other proprietary stop reagents. Additional offerings include Antigens & Antibodies (supplied through partner DIARECT in Germany), Microarray Slides/Surfaces, Protein-Free Diagnostic Reagents, Immunoassay Reagents, and Lateral Flow Reagents. All products are manufactured in an ISO 13485:2016 and ISO 9001:2015 certified facility, and the company provides technical support and R&D assistance to assay developers.

Differentiator

Problem solved

Functional benefit

Brands

• BioFX: Proprietary brand for TMB stop solutions and substrates
• StabilBlot
• StabilCoat
• MatrixGuard
• StabilGuard
• StabilMax
• StabilZyme
• STABILBLOCK
• STABILBLOT
• TRIDIA

Products and services

• ELISA Protein Stabilizers, Diluents & Blockers

Quantifiable outcome

• Less than 5% variation among production lots ensures consistent assay performance
• +4 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

One partnership is on record.

• DIARECTcoreTechnology or IntegrationSurmodics IVD supplies high quality antigens and antibodies from their partner company DIARECT located in Germany. This partnership extends their product portfolio to include biological components essential for immunoassay development.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Danaher Corporation: Danaher owns Beckman Coulter, Leica Biosystems, Cytiva, and Abcam, all of which touch immunoassay reagent and IVD consumable markets where Surmodics IVD competes, making it a broad incumbent rather than a direct specialist competitor.
• Revvity (formerly PerkinElmer): Revvity's Life Sciences and Diagnostics segments include immunoassay reagents, ELISA substrates, and detection chemistries that overlap with Surmodics IVD's portfolio, particularly in clinical and research IVD workflows.
• Merck KGaA / MilliporeSigma: MilliporeSigma is one of the largest life science reagent suppliers globally, offering ELISA substrates, blocking buffers, diluents, and antibodies that directly compete with Surmodics IVD's catalog. It competes on scale and breadth rather than the focused immunoassay niche.
• Thermo Fisher Scientific: Thermo Fisher's Analytical Instruments and Life Sciences Solutions segments include ELISA substrates, detection reagents, and antibodies that overlap with Surmodics IVD's offering. It is the largest incumbent competitor with bundled procurement and broad catalog reach.

Direct peers

• GenScript: GenScript provides custom proteins, antibodies, and assay reagents to diagnostic developers, overlapping with Surmodics IVD's immunoassay reagent and biological components portfolio, particularly for emerging IVD developers.
• Cell Signaling Technology: Cell Signaling Technology supplies high-quality antibodies and immunoassay reagents, overlapping with Surmodics IVD's blocking buffers, diluents, and biological components in Western blot and immunoassay workflows.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies and supporting immunoassay reagents to research and diagnostic customers, overlapping with Surmodics IVD's biological components and Western blot-related product lines.
• Bio-Rad Laboratories: Bio-Rad is a direct competitor in IVD reagents, immunoassay components, substrates, and blocking buffers, and serves the same diagnostic kit developer customer base as Surmodics IVD. Its Life Science segment directly overlaps with Surmodics' portfolio of ELISA substrates, diluents, and stabilizers.
• Bio-Techne: Bio-Techne (R&D Systems, Novus Biologicals, ProteinSimple) supplies proteins, antibodies, and assay reagents to the same diagnostic and life science research customers as Surmodics IVD, with overlapping ELISA and immunoassay reagent catalogs.
• Abcam: Abcam (now part of Danaher) supplies high-quality antibodies and immunoassay reagents to research and diagnostic customers, overlapping directly with Surmodics IVD's antigen/antibody offering via DIARECT and adjacent reagent lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/surmodics-ivd-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surmodics